A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms

Mohammad Mijanur Rahman,Huixin Wu,Trygve O. Tollefsbol
DOI: https://doi.org/10.1038/s41598-024-62084-1
IF: 4.6
2024-05-29
Scientific Reports
Abstract:Estrogen receptor-negative [ER(−)] mammary cancer is the most aggressive type of breast cancer (BC) with higher rate of metastasis and recurrence. In recent years, dietary prevention of BC with epigenetically active phytochemicals has received increased attention due to its feasibility, effectiveness, and ease of implementation. In this regard, combinatorial phytochemical intervention enables more efficacious BC inhibition by simultaneously targeting multiple tumorigenic pathways. We, therefore, focused on investigation of the effect of sulforaphane (SFN)-rich broccoli sprouts (BSp) and withaferin A (WA)-rich Ashwagandha (Ash) combination on BC prevention in estrogen receptor-negative [ER(−)] mammary cancer using transgenic mice. Our results indicated that combinatorial BSp + Ash treatment significantly reduced tumor incidence and tumor growth (~ 75%) as well as delayed (~ 21%) tumor latency when compared to the control treatment and combinatorial BSp + Ash treatment was statistically more effective in suppressing BC compared to single BSp or Ash intervention. At the molecular level, the BSp and Ash combination upregulated tumor suppressors (p53, p57) along with apoptosis associated proteins (BAX, PUMA) and BAX:BCL-2 ratio. Furthermore, our result indicated an expressional decline of epigenetic machinery HDAC1 and DNMT3A in mammary tumor tissue because of combinatorial treatment. Interestingly, we have reported multiple synergistic interactions between BSp and Ash that have impacted both tumor phenotype and molecular expression due to combinatorial BSp and Ash treatment. Our RNA-seq analysis results also demonstrated a transcriptome-wide expressional reshuffling of genes associated with multiple cell-signaling pathways, transcription factor activity and epigenetic regulations due to combined BSp and Ash administration. In addition, we discovered an alteration of gut microbial composition change because of combinatorial treatment. Overall, combinatorial BSp and Ash supplementation can prevent ER(−) BC through enhanced tumor suppression, apoptosis induction and transcriptome-wide reshuffling of gene expression possibly influencing multiple cell signaling pathways, epigenetic regulation and reshaping gut microbiota.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: by using the broccoli sprout extract (BSp) rich in glucosinolates (such as sulfides) and the Ashwagandha (Ash) rich in Ayurvedic components (such as Withaferin A) in combination, to explore its preventive effect on estrogen receptor - negative breast cancer (ER(−) BC) and its mechanism. Specifically, the study aims to evaluate whether this combined intervention can effectively prevent the development and progression of ER(−) BC through epigenetic and gut microbiota mechanisms. ### Research Background - **Importance of the Problem**: Estrogen receptor - negative breast cancer (ER(−) BC) is one of the most aggressive types of breast cancer, with a relatively high metastasis rate and recurrence rate. Currently, traditional treatment methods are often accompanied by adverse short - term or long - term side effects, so it is particularly important to find safe and effective prevention and treatment strategies. - **Research Methods**: The researchers used a transgenic mouse model (C3(1)-SV40 Tag), and these mice can spontaneously develop breast tumors. By administering single or combined broccoli sprout extract (BSp) and Ashwagandha extract (Ash), the researchers evaluated the effects of these interventions on tumorigenesis, growth, and development. - **Research Objectives**: To explore the role of the combination of BSp and Ash in preventing ER(−) BC, and to analyze its molecular and epigenetic mechanisms, as well as its impact on the gut microbiota. ### Main Findings - **Tumor Suppression Effects**: - The combined intervention significantly reduced the tumor incidence rate (about 75%) and growth rate, and at the same time delayed the tumor latency period (about 21%). - The combined intervention is more effective in suppressing breast cancer than a single intervention. - **Molecular Mechanisms**: - The combined intervention up - regulated the expression of tumor - suppressor genes (such as p53, p57) and proteins related to apoptosis (such as BAX, PUMA). - The combined intervention down - regulated the expression of proteins related to epigenetic regulation (such as HDAC1, DNMT3A). - **Transcriptome Changes**: - RNA - seq analysis showed that the combined intervention led to extensive gene expression remodeling, affecting multiple signaling pathways, transcription factor activities, and epigenetic regulation. - **Gut Microbiota Changes**: - The combined intervention changed the composition of the gut microbiota, increased the α - diversity, and samples in different treatment groups showed significant clustering differences in β - diversity analysis. ### Conclusion The results of this study indicate that the combined intervention of the broccoli sprout extract rich in glucosinolates and the Ashwagandha extract rich in Withaferin A can effectively prevent the development of ER(−) BC by enhancing tumor suppression, inducing apoptosis, and extensively remodeling gene expression. In addition, this combined intervention may also play an additional preventive role by changing the gut microbiota.